Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samreen Ijaz

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
Nature|January 28, 2021
Ebola virus antibody decay-stimulation in a high proportion of survivorsCharlene Adaken, Janet T Scott, Raman Sharma, et al.
The Lancet Regional Health. Europe|August 29, 2022
Epidemiology of SARS-CoV-2 infection among staff and students in a cohort of English primary and secondary schools during 2020-2021James R Hargreaves, Sinéad M Langan, William E Oswald, et al.
Transfusion|March 25, 2018
Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra LeoneRichard S Tedder, Dhan Samuel, Steve Dicks, et al.
Transfusion Medicine (Oxford, England)|December 17, 2020
Convalescent plasma therapy for the treatment of patients with COVID-19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levelsHeli Harvala, Matthew L Robb, Nick Watkins, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 10, 2016
Hepatitis E virus: Assessment of the epidemiological situation in humans in Europe, 2014/15Cornelia Adlhoch, Ana Avellon, Sally A Baylis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 11, 2012
The diversity and management of chronic hepatitis B virus infections in the United Kingdom: a wake-up callRichard S Tedder, Alison J Rodger, Lori Fries, et al.
Plos One|February 16, 2022
Secondary attack rates in primary and secondary school bubbles following a confirmed case: Active, prospective national surveillance, November to December 2020, EnglandAnnabel A Powell, Georgina Ireland, Frances Baawuah, et al.
Frontiers in Immunology|April 14, 2023
SARS-CoV-2 antibody responses associate with sex, age and disease severity in previously uninfected people admitted to hospital with COVID-19: An ISARIC4C prospective studyEleanor Parker, Jordan Thomas, Kelly J Roper, et al.
Journal of Virological Methods|January 25, 2022
Detection and quantification of antibody to SARS CoV 2 receptor binding domain provides enhanced sensitivity, specificity and utilityCarolina Rosadas, Maryam Khan, Eleanor Parker, et al.
Iscience|December 13, 2023
Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescentsHelen Ratcliffe, Karen S Tiley, Stephanie Longet, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
Nature|January 28, 2021
Ebola virus antibody decay-stimulation in a high proportion of survivorsCharlene Adaken, Janet T Scott, Raman Sharma, et al.
The Lancet Regional Health. Europe|August 29, 2022
Epidemiology of SARS-CoV-2 infection among staff and students in a cohort of English primary and secondary schools during 2020-2021James R Hargreaves, Sinéad M Langan, William E Oswald, et al.
Transfusion|March 25, 2018
Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra LeoneRichard S Tedder, Dhan Samuel, Steve Dicks, et al.
Transfusion Medicine (Oxford, England)|December 17, 2020
Convalescent plasma therapy for the treatment of patients with COVID-19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levelsHeli Harvala, Matthew L Robb, Nick Watkins, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 10, 2016
Hepatitis E virus: Assessment of the epidemiological situation in humans in Europe, 2014/15Cornelia Adlhoch, Ana Avellon, Sally A Baylis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 11, 2012
The diversity and management of chronic hepatitis B virus infections in the United Kingdom: a wake-up callRichard S Tedder, Alison J Rodger, Lori Fries, et al.
Plos One|February 16, 2022
Secondary attack rates in primary and secondary school bubbles following a confirmed case: Active, prospective national surveillance, November to December 2020, EnglandAnnabel A Powell, Georgina Ireland, Frances Baawuah, et al.
Frontiers in Immunology|April 14, 2023
SARS-CoV-2 antibody responses associate with sex, age and disease severity in previously uninfected people admitted to hospital with COVID-19: An ISARIC4C prospective studyEleanor Parker, Jordan Thomas, Kelly J Roper, et al.
Journal of Virological Methods|January 25, 2022
Detection and quantification of antibody to SARS CoV 2 receptor binding domain provides enhanced sensitivity, specificity and utilityCarolina Rosadas, Maryam Khan, Eleanor Parker, et al.
Iscience|December 13, 2023
Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescentsHelen Ratcliffe, Karen S Tiley, Stephanie Longet, et al.
Pageof 13